advertisement

Oculus

Abstract #84974 Published in IGR 21-1

Neuroprotection from optic nerve injury and modulation of oxidative metabolism by transplantation of active mitochondria to the retina

Nascimento-Dos-Santos G; Nascimento-Dos-Santos G; de-Souza-Ferreira E; Lani R; Faria CC; Araújo VG; Araújo VG; Teixeira-Pinheiro LC; Vasconcelos T; Gonçalo T; Gonçalo T; Santiago MF; Linden R; Galina A; Petrs-Silva H; Petrs-Silva H
Biochimica et Biophysica Acta - Molecular Basis of Disease 2020; 1866: 165686

See also comment(s) by Jonathan CrowstonKeith Martin


Mitochondrial dysfunctions are linked to a series of neurodegenerative human conditions, including Parkinson's disease, schizophrenia, optic neuropathies, and glaucoma. Recently, a series of studies have pointed mitotherapy - exogenous mitochondria transplant - as a promising way to attenuate the progression of neurologic disorders; however, the neuroprotective and pro-regenerative potentials of isolated mitochondria in vivo have not yet been elucidated. In this present work, we tested the effects of transplants of active (as well-coupled organelles were named), liver-isolated mitochondria on the survival of retinal ganglion cells and axonal outgrowth after optic nerve crush. Our data show that intravitreally transplanted, full active mitochondria incorporate into the retina, improve its oxidative metabolism and electrophysiological activity at 1 day after transplantation. Moreover, mitotherapy increases cell survival in the ganglion cell layer at 14 days, and leads to a higher number of axons extending beyond the injury site at 28 days; effects that are dependent on the organelles' structural integrity. Together, our findings support mitotherapy as a promising approach for future therapeutic interventions upon central nervous system damage.

Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-901, Brazil. Electronic address: gabriel.nascimento@biof.ufrj.br.

Full article

Classification:

11.8 Neuroprotection (Part of: 11 Medical treatment)



Issue 21-1

Select Issue


advertisement

Oculus